Atalanta Sosnoff Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $328K | Buy |
7,093
+301
| +4% | +$13.9K | 0.01% | 89 |
|
2025
Q1 | $414K | Buy |
6,792
+979
| +17% | +$59.7K | 0.01% | 74 |
|
2024
Q4 | $329K | Buy |
5,813
+406
| +8% | +$23K | 0.01% | 83 |
|
2024
Q3 | $280K | Hold |
5,407
| – | – | 0.01% | 91 |
|
2024
Q2 | $225K | Sell |
5,407
-210
| -4% | -$8.72K | 0.01% | 85 |
|
2024
Q1 | $305K | Buy |
+5,617
| New | +$305K | 0.01% | 87 |
|
2020
Q4 | – | Sell |
-129,430
| Closed | -$7.8M | – | 100 |
|
2020
Q3 | $7.8M | Sell |
129,430
-2,639
| -2% | -$159K | 0.22% | 70 |
|
2020
Q2 | $7.77M | Buy |
+132,069
| New | +$7.77M | 0.23% | 69 |
|
2019
Q1 | – | Sell |
-548,824
| Closed | -$28.5M | – | 89 |
|
2018
Q4 | $28.5M | Buy |
+548,824
| New | +$28.5M | 1.04% | 40 |
|
2017
Q1 | – | Sell |
-520,169
| Closed | -$30.4M | – | 102 |
|
2016
Q4 | $30.4M | Buy |
+520,169
| New | +$30.4M | 1.08% | 37 |
|
2016
Q3 | – | Sell |
-455,918
| Closed | -$33.5M | – | 107 |
|
2016
Q2 | $33.5M | Sell |
455,918
-28,502
| -6% | -$2.1M | 1.12% | 35 |
|
2016
Q1 | $30.9M | Sell |
484,420
-30,896
| -6% | -$1.97M | 0.97% | 41 |
|
2015
Q4 | $35.4M | Buy |
515,316
+24,174
| +5% | +$1.66M | 1.05% | 41 |
|
2015
Q3 | $29.1M | Sell |
491,142
-41,642
| -8% | -$2.47M | 0.93% | 45 |
|
2015
Q2 | $35.5M | Buy |
532,784
+466,592
| +705% | +$31M | 0.97% | 44 |
|
2015
Q1 | $4.27M | Buy |
+66,192
| New | +$4.27M | 0.11% | 62 |
|
2014
Q2 | – | Sell |
-621,929
| Closed | -$32.3M | – | 96 |
|
2014
Q1 | $32.3M | Sell |
621,929
-49,380
| -7% | -$2.57M | 0.72% | 44 |
|
2013
Q4 | $35.7M | Buy |
+671,309
| New | +$35.7M | 0.77% | 49 |
|